Apis Capital Advisors LLC Lowers Stake in Edap Tms S.A. (NASDAQ:EDAP)

Apis Capital Advisors LLC lessened its stake in shares of Edap Tms S.A. (NASDAQ:EDAP) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 541,000 shares of the medical equipment provider’s stock after selling 4,976 shares during the quarter. Edap Tms makes up about 2.2% of Apis Capital Advisors LLC’s portfolio, making the stock its 18th biggest position. Apis Capital Advisors LLC owned approximately 1.46% of Edap Tms worth $2,943,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Virtu Financial LLC purchased a new stake in shares of Edap Tms during the 1st quarter worth $82,000. Miracle Mile Advisors LLC bought a new position in Edap Tms in the first quarter worth about $136,000. Roubaix Capital LLC purchased a new stake in shares of Edap Tms during the first quarter valued at about $169,000. Finally, Commonwealth Equity Services LLC boosted its holdings in shares of Edap Tms by 5.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after buying an additional 4,000 shares in the last quarter. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

EDAP has been the subject of a number of analyst reports. StockNews.com cut shares of Edap Tms from a “hold” rating to a “sell” rating in a research report on Tuesday, September 3rd. HC Wainwright reaffirmed a “buy” rating and set a $19.00 price target on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Stock Performance

EDAP opened at $3.05 on Monday. The company has a market cap of $113.17 million, a P/E ratio of -5.65 and a beta of 0.43. The company has a quick ratio of 1.80, a current ratio of 2.45 and a debt-to-equity ratio of 0.03. The firm’s 50-day moving average price is $4.05 and its 200-day moving average price is $5.65. Edap Tms S.A. has a 52-week low of $2.71 and a 52-week high of $8.50.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The company had revenue of $16.97 million for the quarter, compared to analysts’ expectations of $17.16 million. Edap Tms had a negative return on equity of 36.41% and a negative net margin of 31.68%. As a group, equities analysts anticipate that Edap Tms S.A. will post -0.59 EPS for the current fiscal year.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.